Literature DB >> 6588264

Early dietary protein and phosphorus restriction is effective in delaying progression of chronic renal failure.

G Maschio, L Oldrizzi, N Tessitore, A D'Angelo, E Valvo, A Lupo, C Loschiavo, A Fabris, L Gammaro, C Rugiu.   

Abstract

A diet containing about 40 kcal/kg, 0.6 g/kg of protein, 700 mg of phosphorus, and 1,000 to 1,500 mg of calcium (orally supplemented) was prescribed to three groups of patients with chronic renal failure for 6 to 76 months. The mean serum creatinine values were 2.18 mg/dl in group 1 (25 patients), 4.24 mg/dl in group 2 (20 patients), and 6.10 mg/dl in group 3 (8 patients). An additional group of 30 patients (group 4) who had followed no specific dietary treatment for 3 to 72 months was taken as control. The plots of reciprocal serum creatinine against time gave slopes of -0.0008, -0.0010, and -0.0041 in the three groups of patients on the protein-restricted diet, and a slope of -0.020 in the patients on the free diet. The differences between the slopes in patients in groups 1, 2, and 3 versus that in patients in group 4 are statistically significant (analysis of variance and F ratio: P less than 0.01). During the follow-up period a decline in reciprocal serum creatinine greater than the mean values in the whole group was observed in 37.5% of patients in group 3, in 20% of those in group 2, and in only 12% of those in group 1. Thus, the degree of functional renal deterioration is critical in modulating the effects of dietary protein and phosphorus restriction. Several nonimmunologic factors, including hypertension, infection, electrolyte abnormalities, and low-calorie intake, appeared to play an important role in influencing the rate of progression of renal failure in patients on dietary protein restriction.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6588264

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  8 in total

Review 1.  Recognition and management of IgA nephropathy.

Authors:  L S Ibels; A Z Gyory; R J Caterson; C A Pollock; J F Mahony; D A Waugh; S Coulshed
Journal:  Drugs       Date:  1998-01       Impact factor: 9.546

Review 2.  Nutritional treatment in chronic kidney disease: the concept of nephroprotection.

Authors:  Eleonora Riccio; Antonella Di Nuzzi; Antonio Pisani
Journal:  Clin Exp Nephrol       Date:  2014-10-16       Impact factor: 2.801

Review 3.  Contextual poverty, nutrition, and chronic kidney disease.

Authors:  Orlando M Gutiérrez
Journal:  Adv Chronic Kidney Dis       Date:  2015-01       Impact factor: 3.620

Review 4.  Contribution of phosphate and FGF23 to CKD progression.

Authors:  Kyle P Jansson; Alan S L Yu; Jason R Stubbs
Journal:  Curr Opin Nephrol Hypertens       Date:  2022-03-11       Impact factor: 3.416

5.  The influence of two different essential amino acid/keto analogue preparations on the clinical status of patients with chronic renal failure.

Authors:  E Meisinger; M Strauch
Journal:  Z Ernahrungswiss       Date:  1985-06

6.  Effect of antihypertensive drugs on glomerular hyperfiltration and renal haemodynamics. Comparison of captopril with nifedipine, metoprolol and celiprolol.

Authors:  J Böhler; A Becker; P Reetze-Bonorden; R Woitas; E Keller; P Schollmeyer
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

7.  The calcium channel blocker nisoldipine delays progression of chronic renal failure in humans (preliminary communication).

Authors:  H E Eliahou; D Cohen; A Ben-David; D Herzog; I Serban; S Gavendo; S Kapuler; N Kogan; B Hellberg
Journal:  Cardiovasc Drugs Ther       Date:  1988-01       Impact factor: 3.727

8.  Phosphate-Induced Renal Fibrosis Requires the Prolyl Isomerase Pin1.

Authors:  Zhong-Jian Shen; Jie Hu; Kazuhiro Shiizaki; Makoto Kuro-o; James S Malter
Journal:  PLoS One       Date:  2016-02-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.